MUL is among the largest state-owned medical Universities in Poland. It has reached a leading position in the following research areas: immunology, molecular biology, genetics of homeostasis disorders, oncology, hypertension and endocrinology. Within the last two years, young researchers from MUL were considered leaders in areas such as cardiology, oncology, immunology and dermatology.

With over 40,000 students and more than 9,500 employees, UCPH – founded 1479 – is among the largest comprehensive universities in Europe. It is ranked No. 7 in Europe and no. 39 in the world in the Academic Ranking of World Universities 2015. The University has an international environment where ambitious researchers and students strive for new knowledge and insights. UCPH is placed at the centre of a stimulation entrepreneurial ecosystem in the Greater Copenhagen Area.

The Medical University of Gdańsk (MUG) is a modern academic center widely acclaimed both nationally and internationally. University is characterized by high scientific and development potential, which consists of experience, reputable research teams, increasing number of prestigious international publications and grants, as well as a wide range and quality of conducted research confirmed by high categorization of units. The MUG is the only medical university in the country – that has been selected to the elite group of the top 10 best Polish universities awarded in the prestigious Excellence Initiative – Research University competition. Moreover, it is the best medical university in Poland according to the latest edition ot the Perspektywy educational foundation ranking. The MUG educates more than 6000 students, doctoral students and postgraduate students. Among them, there are 935 foreign students, which is over 15 percent of all students. The University educates in all medical professions, based on a modern teaching and clinical infrastructure. - The Medical University of Gdańsk successfully implements a policy stimulating the growth of innovation based on the results of scientific research and development works carried out at the University through the transfer of knowledge to industry and strengthening cooperation with the socio-economic environment at national and international level – said Katarzyna Waligóra-Borek, Ph.D., Acting Director of Technology Transfer Office of the MUG - Intensification of the commercialization of research results is one of the goals of our University's development strategy until 2025, as well as the tasks that we will implement as part of the program “Excellence Initiative – Research University”. The well-established partnership will allow us to use our mutual potential more effectively.

The Boehringer Ingelheim Regional Center Vienna is responsible for Boehringer Ingelheim's prescription and veterinary medicines business in Austria and more than 30 countries in Central and Eastern Europe, Central Asia, Switzerland and Israel. In addition, all clinical research is managed from Vienna. Vienna is also the main centre for cancer research and the location for biopharmaceutical research, development and production for the entire group.

DEX Innovation Centre (DEX IC) is a private innovation center established in 2012. We are a social enterprise. We believe that impactful digital innovation and research improve society and this is thus our Mission. We learned that digital-based innovation is applicable in many sectors, but in some particular ones, the impact on societies is the highest. We focus on them. Health, Energy and Transportation are such sectors, among a few others (like Digital security).

Roche is the world's largest biotech company, with medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche also leads in in-vitro diagnostics, tissue-based cancer diagnostics and in-diabetes management.

FreshBlood is a project that is focused on improving healthcare through technology, by providing feedback, support, mentoring and exposure.

MADoPA is a Living Lab specialising in co-creation, experimentation and evaluation of technologies and services for the elderly. MADoPA is a non profit association created in 2009, financially independent and involved in multiple European, national and regional projects.

At Maastricht University, innovation is our focus. Problem-based learning and research-based learning are key. We focus on multidisciplinary topics and issues that are critical to the development of society, both today and tomorrow.

BioInnovate Ireland is a forum which combines resources to catalyse and lead medical innovation. Its training programme aims to act as a neutral territory where academia, clinicians and industry can collaborate on developing novel medical technologies. The programme is an active partnership between multiple universities (NUI Galway, University of Limerick and University College Cork). It engages with hospitals all over the country, and is supported by Enterprise Ireland, IMDA and multiple industry sponsors.

Founded in 1743, FAU has a rich history. It is a strong research university with an international perspective and one of the largest universities in Germany, with 39,780 students, 265 degree programmes and 4,000 academic staff. At Universitätsklinikum Erlangen (the university hospital), 7.400 employees promote health and cure disease. With up-to-date equipment and science-based diagnostic and therapeutic procedures, the 24 departments of the FAU, 25 clinical departments, 19 institutes, and 21 independent departments at Universitätsklinikum Erlangen comprehend every field of modern medicine.

Karolinska Institutet is one of the world's leading medical Universities. Our mission is to contribute to the improvement of human health through research and education. Our research covers the entire medical field, from basic molecular biological research, to clinical epidemiology and nursing science. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine. With our close relationship to the clinical world, a well-established infrastructure, a unique innovation system and financial stability, Karolinska Institutet has excellent prerequisites for sustaining high-quality research and education.